Triple therapy with sucralfate, amoxycillin and metronidazole for healing duodenal ulcer and eradicating Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 2, 1996, Pages 193-197

  Stupnicki, Th ^a   Taufer, M ^b   Denk, H ^b   Ratschek, M ^b   Spath, P ^a   Graf, K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CERULENIN; METRONIDAZOLE; SUCRALFATE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; DRUG EFFICACY; ENDOSCOPY; FEMALE; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH BIOPSY;

EID: 0029987015     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.720100000.x     Document Type: Article

References (30)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273-5.
2. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311-5.
3. Graham DY, Lew GM, Evans DH, Evans J, Klein PD. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann Intern Med 1991; 115: 226-9.
4. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992; 102: 1716-27.
5. Forbes GM, Glaser ME, Cullen DJE, Warren JR. Duodenal ulcer treated with Helicobacter pylori eradication: seven year follow up. Lancet 1994; 343: 258-60.
6. Mannes GA, Bayerdörffer E, Höchter W, et al. Decreased relapse rate after antibacterial treatment of Helicobacter pylori-associated duodenal ulcers. Munich duodenal ulcer trial. Eur J Gastroenterol Hepatol 1993; 5: 145-53.
7. Bayerdörffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxycillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 697-702.
8. Labenz J, Rühl GH, Bertrams J, Börsch G. Clinical course of duodenal ulcer disease one year after omeprazole plus amoxycillin or triple therapy plus ranitidine for cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994; 6: 293-7.
9. Labenz J, Rühl GH, Bertrams J, Börsch G. Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease. Aliment Pharmacol Ther 1994; 8: 323-7.
10. Joseph JY, Sung MD, Sydney Chung SC, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-42.
11. Hentschel E, Brandstätter G, Dragosics B, et al. Effect of ranitidine and amoxycillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-12.
12. Dorval EB, Loulerque J, Barbieux JP, Metman EH, De Muret A. Helicobacter pylori et maladie ulcéreuse duodenale. Resultats à long terme d'une tri-thérapie sucralfate-antibiotiques. Gastroenterol Clin Biol 1991; 15: 863-4.
13. George LG, Borody TJ, Andrews P, et al. Care of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990; 153: 145-9.
14. Borody TJ, Cole P, Noonan S, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151: 431-5.
15. Axon ATR. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastroenterol Hepatol 1991; 16: 131-7.
16. Slomiany BL, Slomiany A. Role of mucus in gastric mucosal protection. J Physiol Pharmacol 1991; 42: 149-63.
17. Slomiany BL, Murty VLN, Pietrowsky J, et al. Glyco sulfatase activity of Helicobacter pylori toward human gastric mucin: effect of sucralfate. Am J Gastroenterol 1992; 87: 1132-7.
18. Slomiany BL, Pietrowsky J, Slomiany A. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and upases. Am J Gastroenterol 1992; 87: 595-9.
19. Nakajima M, Sunairi M, Tanaka N, Kuwayama H. Effects of sucralfate an antiulcer agent on Helicobacter pylori. Gastroenterology 1992; 102: A131.
20. Rautelin H, Sepällä K, Renhonen OV, Vairo U, Kosunen TU. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992; 36: 163-6.
21. Van Zwet HH, Thijs JC, Schievnik W, et al. In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother 1994; 38: 360-2.
22. Hirschl AM, Hentschel E, Berger J, Nemec H, Rotter LM. Treatment of Helicobacter pylori infections with amoxycillin plus metronidazole. Bacteriological, serological and histological results. Eur J Gastroenterol Hepatol 1991; 3: 3-7.
23. Sung JJY, Chung SCS, Ling ThKVV, et al. One-year follow-up of duodenal ulcers after 1-wk triple therapy for Helicobacter pylori. Am J Gastroenterol 1994; 89: 199-202.
24. Marks IN. Sucralfate - safety and side effects. Scand J Gastroenterol 1991; 185 (Suppl.): 36-42.
25. Marks IN. The efficacy safety and dosage of sucralfate in ulcer therapy. Scand J Gastroenterol 1987; 22 (Suppl. 140): 33-8.
26. Glupczynski Y, Burette A. Drug therapy of Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1989; 85: 1545-51.
27. Glupczynski Y. Metronidazole resistance in Helicobacter pylori: results of the second multicenter in vitro study. Ital J Gastroenterol 1991; 23 (Suppl. 2): 107 (Abstract).
28. Noach LA, Langenberg WL, Bertola MA, Dankert J, Tytgat GNJ. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis 1994; 26: 321-7.
29. Logan RPH, Gummett PA, Misiewicz JJ, Karim QN, Walker MM, Baron JH. One week eradication regimen for Helicobacter pylori. Lancet 1991; 338: 1249-52.
30. Glupczynski Y, Burette A, De Koster E, et al. Metronidazole resistance in Helicobacter pylori. Lancet 1990; 335: 976-7 (Letter).